US FDA approves Regeneron’s rare bone disorder drug
US FDA approves Regeneron's rare bone disorder drug Reuters
Regulatory Approvals
Regeneron drug for disease that causes dangerous bone growth earns FDA approval
Regeneron drug for disease that causes dangerous bone growth earns FDA approval STAT
FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for…
FDA Approves First Drug to Treat a Cause of Narcolepsy
FDA Approves First Drug to Treat a Cause of Narcolepsy Time Magazine
Is BASF (XTRA:BAS) Undervalued After FDA Approval Of Its Tinosorb S UV Filter?
Is BASF (XTRA:BAS) Undervalued After FDA Approval Of Its Tinosorb S UV Filter? Yahoo Finance